Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Eur Urol Oncol. 2019 Oct 23;3(6):748–755. doi: 10.1016/j.euo.2019.09.006

Table 2 –

Grade 2 toxicity estimatesa

Timing
Acute Late
Grade 2 toxicity Rate (%) 95% CI (%) Fraction Rate (%) 95% CI (%) Fraction
Any GI toxicity 1.8 0.9–3.3 10/551 3.6 2.2–5.6 20/551
Diarrhea 0.2 0–1.0 1/551 0.5 0.1–1.6 3/551
GI hemorrhage 0.2 0–1.0 1/551 2.2 1.1–3.8 12/551
Hemorrhoids 0.7 0.2–1.8 4/551 1.5 0.6–2.8 8/551
Proctitis 0.9 0.3–2.1 5/551 0.5 0.1–1.6 3/551
Any GU toxicity 10.2 7.8–13.0 56/551 22.7 19.3–26.4 125/551
Cystitis 0.9 0.3–2.1 5/551 0.4 0–1.3 2/551
Frequency/urgency 8.7 6.5–11.4 48/551 14.3 11.5–17.5 79/551
Incontinence 0.9 0.3–2.1 5/551 2.9 1.7–4.7 16/551
GU hemorrhage 0.0 0–0.7 0/551 2.0 1–3.5 11/551
Retention 2.2 1.1–3.8 12/551 8.7 6.5–11.4 48/551
Urinary stricture 0.5 0.1–1.6 3/551

CI = confidence interval; GI = gastrointestinal; GU = genitourinary.

a

Acute urinary stricture was not measured. Fifty-six patients had any grade 2 GU acute toxicity, but one of these patients also had Grade 3 toxicity. Therefore, 55 patients had a maximum grade of 2. Twenty patients had any grade 2 GI late toxicity, but one of these patients also had grade 3 toxicity. Therefore, 19 patients had a maximum grade of 2.